<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0030">
 <label>Table 6</label>
 <caption>
  <p>Impacts of CCR5Δ32 on various viral infections.</p>
 </caption>
 <alt-text id="at0110">Table 6</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Pathogen/Disease</th>
    <th align="left">Population</th>
    <th align="left">Sample</th>
    <th align="left">Main findings</th>
    <th align="left">References</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">Poliovirus (PV) infection</td>
    <td align="left">Finnish</td>
    <td align="left">7 PV-infected individuals with neurological symptoms;79 non-infected individuals or asymptomatic infected individuals</td>
    <td align="left">No association between CCR5Δ32 and severe PV-associated neurologic disease (small sample size study)</td>
    <td align="left">
     <xref rid="bib1225" ref-type="bibr">Rosenberg et al. (2013)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" valign="middle" rowspan="3">Dengue virus (DENV) infection</td>
    <td align="left">Brazilian</td>
    <td align="left">87 DENV-infected children (severe cases); 326 controls</td>
    <td align="left">No statistical association between CCR5Δ32 and DENV infection</td>
    <td align="left">
     <xref rid="bib1635" ref-type="bibr">Xavier-Carvalho et al. (2013)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Australian</td>
    <td align="left">56 DENV-infected individuals; 91 non-infected individuals</td>
    <td align="left">No statistical association between CCR5Δ32 and DENV infection</td>
    <td align="left">
     <xref rid="bib0175" ref-type="bibr">Brestovac et al. (2014)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Indian</td>
    <td align="left">42 DENV-infected individuals (33 mild cases and 9 severe cases); 90 non-infected individuals</td>
    <td align="left">The CCR5Δ32 allele was not detected in any individuals included in the study</td>
    <td align="left">
     <xref rid="bib0680" ref-type="bibr">Islam et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" valign="middle" rowspan="2">Human cytomegalovirus (CMV) infection</td>
    <td align="left">European-American; African-American</td>
    <td align="left">203 European-American and 117 African-American individuals with AIDS and CMV retinitis</td>
    <td align="left">No statistical association between CCR5Δ32 (as an individual factor) and mortality, retinitis progression or retinal detachment</td>
    <td align="left">
     <xref rid="bib1330" ref-type="bibr">Sezgin et al. (2011)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Polish</td>
    <td align="left">72 children with intrauterine CMV infection; 398 non-infected children</td>
    <td align="left">No statistical association between CCR5Δ32 and CMV infection</td>
    <td align="left">
     <xref rid="bib0710" ref-type="bibr">Kasztelewicz et al. (2017)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" valign="middle" rowspan="2">Crimean-Congo hemorrhagic fever virus (CCHFV) infection</td>
    <td align="left">Turkish</td>
    <td align="left">3 CCHFV fatal cases; 12 CCHFV non-fatal cases</td>
    <td align="left">All individuals had the wild-type genotype</td>
    <td align="left">
     <xref rid="bib0440" ref-type="bibr">Engin et al. (2009)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Turkish</td>
    <td align="left">133 CCHFV-infected individuals; 97 non-infected individuals</td>
    <td align="left">The CCR5Δ32 heterozygous genotype and the Δ32 allele were associated with protection against CCHFV infection (both factors found in increased frequency in control group)</td>
    <td align="left">
     <xref rid="bib1245" ref-type="bibr">Rustemoglu et al. (2017)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Enterovirus (EV) infection</td>
    <td align="left">German</td>
    <td align="left">97 individuals with enteroviral cardiomyopathy (23 individuals with persistent EV infection; 42 individuals who spontaneously cleared the virus; 32 individuals with persistent EV infection who received interferon-β therapy to clear the virus)</td>
    <td align="left">CCR5Δ32 was associated with spontaneous viral clearance and better clinical outcome (all Δ32 allele carriers showed viral clearance and none of them died during the study period)</td>
    <td align="left">
     <xref rid="bib0835" ref-type="bibr">Lassner et al. (2018)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Japanese encephalitis virus (JEV) infection</td>
    <td align="left">Indian</td>
    <td align="left">183 JEV-infected individuals; 361 non-infected individuals</td>
    <td align="left">No statistical association between the CCR5Δ32 and Japanese encephalitis considering the CCR5Δ32 as an individual factor</td>
    <td align="left">
     <xref rid="bib0340" ref-type="bibr">Deval et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Nephropathia epidemica (linked to hantavirus infection)</td>
    <td align="left">Russian (Republic of Tatarstan)</td>
    <td align="left">98 nephropathia epidemica cases; 592 controls</td>
    <td align="left">CCR5Δ32 did not affect susceptibility to hantavirus infection. However, the wild-type homozygous genotype was associated with more severe disease</td>
    <td align="left">
     <xref rid="bib0760" ref-type="bibr">Kletenkov et al. (2019)</xref>
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
